Xeris Biopharma
XERS | NASDAQ
$16.70
+$0.04 (+0.24%)
At close: Nov 16, 2026, 4:00 PM ET
$16.49
-$0.21 (-1.26%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Xeris Biopharma Statistics
Key statistics explainedMarket Data
$3.05B
$3.15B
0.84
2.26M
189.92M
6.93%
63.50%
NASDAQ
US98422E1038
Price Performance
62.0%
96.0%
177.9%
112.7%
130.0%
843.5%
581.6%
62.0%
132.6%
47.5%
-2.3%
Valuation
-363.83
28,053.29
0.04
22.47
8.29
5.80
62.54
42.01
73.80
42.82
8.54
228.13
119.69
43.32
-0.3%
2.4%
1.4%
Financial Health
$58.63M
$226.07M
$131.08M
$423.22M
2.15
1.58
4.63
8.60
3.11
0.33
1.70
4.02
6
Margins & Profitability
84.4%
12.7%
7.1%
-1.8%
19.7%
11.2%
8.5%
-43.1%
Returns
-1.5%
-39.5%
15.8%
16.2%
-2.0%
Historical Growth (CAGR)
34.1%
59.8%
N/A
101.7%
55.6%
N/A
325.7%
164.1%
N/A
Analyst Forecasts
Buy
5
883.3%
26.3%
Mar 1, 2027
$0.06
0.0%
$119.03M
38.7%
Fair Value Estimates
N/A
N/A
N/A
N/A
$15.00
-10.2%
Cash Flow
$73.65M
$72.62M
$41.34M
$0.38
$0.39
20.0%
Income Statement
$368.26M
$310.96M
$46.78M
$26.29M
$-6.5M
-$0.05
$846.57K
$-14.93K
435
Add to Watchlist
Select watchlists to add or remove XERS